Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 169

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Type 1 Diabetes—A Clinical Perspective

Open access
Kahanovitz, Lindy, Sluss, Patrick M., Russell, Steven J. · 2017 · Point of Care: The Journal of Near-Patient Testing & Technology

Abstract

Type 1 diabetes mellitus is a disorder of glucose regulation characterized by autoimmune destruction of the insulin-producing pancreatic β-cells and the need for lifelong insulin replacement therapy. Both glucose and HbA1c criteria are available for the diagnosis of diabetes. Achieving and maintaining near-normal blood glucose concentrations with appropriate administration of insulin is critical for successful long-term care of patients with diabetes mellitus and prevention of diabetic complications, but it is very difficult to achieve. Efforts to intensify therapy usually result in hypoglycemia. Point-of-care blood glucose testing provides the information needed by patients for clinical decision-making. Despite the ease of use and rapid reporting of modern point-of-care glucose monitoring devices, they provide measurements only intermittently. Continuous glucose monitoring devices can provide new glucose measurements every 5 minutes and may facilitate better glucose control. The development of new technologies that integrate continuous glucose monitoring technology with insulin pumps and a control algorithm to create a system for automated insulin delivery has the potential to significantly improve glycemic control, reduce hypoglycemia, and reduce the burden of care in type 1 diabetes mellitus.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/poc.0000000000000125

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 20

  1. 2016, Classification and diagnosis of diabetes. Standard of Medical Care in Diabetes, Diabetes Care, 39, S13, 10.2337/dc16-S005 · DOI · Paper page
  2. 2012, Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay, Diabetes Care, 35, 465, 10.2337/dc11-1236 · DOI · Paper page
  3. 2015, Low levels of C-peptide have clinical significance for established Type 1 diabetes, Diabet Med, 32, 1346, 10.1111/dme.12850 · DOI · Paper page
  4. 2015, Current concepts on the pathogenesis of type 1 diabetes—considerations for attempts to prevent and reverse the disease, Diabetes Care, 38, 979, 10.2337/dc15-0144 · DOI
  5. 1999, Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation, J Immunol, 163, 525, 10.4049/jimmunol.163.1.525 · DOI
  6. 2013, Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry, J Clin Endocrinol Metab, 98, 3411, 10.1210/jc.2013-1589 · DOI · Paper page
  7. 2010, 2010 Consensus statement on the worldwide standardization of the hemoglobin A1C measurement, Diabetes Care, 33, 1903, 10.2337/dc10-0953 · DOI · Paper page
  8. 2016, Glycemic Targets. Standards of Medical Care in Diabetes—2016, Diabetes Care, 39, S39
  9. 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
  10. 2011, Point-of-care blood test for ketones in patients with diabetes: primary care diagnostic technology update, Br J Gen Pract, 61, 530, 10.3399/bjgp11X588600 · DOI
  11. 2007, Improving outcomes with POCT for HbA1c and blood ketone testing, J Diabetes Sci Technol, 1, 133, 10.1177/193229680700100122 · DOI
  12. 2002, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus, JAMA, 287, 2563, 10.1001/jama.287.19.2563 · DOI · Paper page
  13. 2014, Closed-loop artificial pancreas systems: engineering the algorithms, Diabetes Care, 37, 1191, 10.2337/dc13-2108 · DOI · Paper page
  14. 2014, The artificial pancreas: current status and future prospects in the management of diabetes, Ann N Y Acad Sci, 1311, 102, 10.1111/nyas.12431 · DOI · Paper page
  15. 2014, Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study, Diabetes Care, 37, 1931, 10.2337/dc13-2911 · DOI
  16. 2014, Outpatient glycemic control with a bionic pancreas in type 1 diabetes, N Engl J Med, 371, 313, 10.1056/NEJMoa1314474 · DOI · Paper page
  17. 2006, Feasibility of automating insulin delivery for the treatment of type 1 diabetes, Diabetes, 55, 3344, 10.2337/db06-0419 · DOI · Paper page
  18. 2010, Efficacy determinants of subcutaneous microdose glucagon during closed-loop control, J Diabetes Sci Technol, 4, 1288, 10.1177/193229681000400602 · DOI
  19. 2014, Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes, J Clin Endocrinol Metab, 99, 1701, 10.1210/jc.2013-4151 · DOI
  20. 2016, Development of a microsphere-based system to facilitate real-time insulin monitoring, J Diabetes Sci Technol, 10, 689, 10.1177/1932296815625081 · DOI

Cited by

See all 169

Metadata

Authors
Kahanovitz, L., Sluss, P. M., & Russell, S. J.
Venue
Point of Care: The Journal of Near-Patient Testing & Technology
Published
2017-03
Volume
16
Issue
1
Pages
37-40
ISSN
  • 1533-029X (ISSN-L)
  • 1533-0303
OpenAlex
W2589143196
Cited by
169
References
15
FWCI
2.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type 1 Diabetes—A Clinical Perspective. https://app.cochat.ai/papers/10.1097/poc.0000000000000125
The paper
Kahanovitz, L., Sluss, P. M., & Russell, S. J. (2017). Type 1 Diabetes—A Clinical Perspective. Point of Care: The Journal of Near-Patient Testing & Technology. https://doi.org/10.1097/poc.0000000000000125

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.